- Home
- Products
Exkivity (Mobocertinib)
Exkivity (Mobocertinib)
- Medicine Name: Exkivity
- Generic Name: Mobocertinib
- Dosage Form & Strength: Capsules – 40 mg
- Manufactured By: Takeda Pharmaceutical Company Limited
Exkivity is an oral tyrosine kinase inhibitor (TKI) indicated for the treatment of adult patients with:
- Locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations,
- Whose disease has progressed on or after platinum-based chemotherapy
Recommended Dosage:
- 160 mg orally once daily, with or without food, until disease progression or unacceptable toxicity
- Swallow capsules whole without chewing, opening, or dissolving
- If a dose is missed by more than 6 hours, skip and take the next dose as scheduled.
- If vomiting occurs, do not retake the dose. Continue with the next scheduled dose.
QTc Prolongation & Torsades de Pointes: May be fatal. Evaluate and correct electrolyte imbalances before initiating therapy. Monitor ECG and electrolytes regularly.
Interstitial Lung Disease (ILD)/Pneumonitis: Potentially fatal. Monitor for pulmonary symptoms. Discontinue permanently if ILD/pneumonitis is confirmed.
Cardiac Toxicity: May lead to heart failure. Assess left ventricular function periodically. Adjust dosage or discontinue based on severity.
Severe Diarrhea: Initiate antidiarrheal treatment at first sign. Monitor hydration and electrolytes. Adjust dose if diarrhea is severe.
Pancreatic Toxicity: Monitor amylase and lipase levels regularly, especially in patients with a history of pancreatitis.
Pregnancy & Breastfeeding Risk: May cause fetal harm. Verify pregnancy status before starting. Avoid breastfeeding during treatment and for 7 days after final dose.
To import Exkivity (Mobocertinib) via GlobalRareMeds, the following documents are required:
- A valid prescription from a licensed oncologist
- Diagnostic reports confirming NSCLC with EGFR exon 20 mutation
- Patient’s government-issued ID proof
Order Confirmation:
Orders are confirmed only after verification of the above documents. An import permit may be needed based on regional regulations.
GlobalRareMeds sources Exkivity capsules (40 mg) through authorized global partners across USA, Canada, Europe, and Australia.
Our fulfillment center in Ambernath, Thane District ensures secure processing, pharmacist verification, and compliant delivery.
We deliver across:
- India – Mumbai, Delhi, Chennai, Hyderabad, Bangalore, Kolkata, Pune, Ahmedabad, and more
- Global locations, subject to import regulations
📧 Email: info@globalraremeds.com
📞 Call/WhatsApp: +91-99675 15602
Q. What is the generic name of Exkivity?
A. The generic name is Mobocertinib.
Q. Who manufactures Exkivity?
A. Exkivity is manufactured by Takeda Pharmaceutical Company Limited.
Q. Is Exkivity FDA approved?
A. Yes, FDA approval was granted on September 15, 2021.
Q. What is Exkivity used for?
A. Exkivity is used for treating NSCLC with EGFR exon 20 insertion mutations after progression on platinum-based chemotherapy.
Q. What is the available dosage form of Exkivity?
A. Exkivity is available as 40 mg oral capsules.
Q. What are the common side effects of Exkivity?
A. Common side effects include:
Rash, diarrhea, nausea, stomatitis, vomiting, fatigue, decreased appetite, dry skin, paronychia, and musculoskeletal pain.
Q. Can Exkivity be taken during pregnancy or breastfeeding?
A. No. Exkivity may cause fetal harm. Pregnancy should be avoided. Do not breastfeed during and for at least 7 days after the last dose.
Q. How should Exkivity be stored?
A. Store at 20°C to 25°C (68°F to 77°F). Excursions between 15°C and 30°C (59°F to 86°F) are permitted.
Q. How can I buy Exkivity in India?
A. Submit your prescription and medical documents to GlobalRareMeds. We ensure regulated access and reliable delivery across India and international destinations.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
